Novel oral anticoagulants in the emergency room

European Heart Journal

Volumn 35, Issue 28, 2014, Pages 1829-1830

  Diener, Hans Christoph ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; APIXABAN; DABIGATRAN; EDOXABAN; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RIVAROXABAN; TRIPHENYLTETRAZOLIUM; VITAMIN K GROUP; WARFARIN; ANTIDOTE;

ANTICOAGULANT THERAPY; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; DRUG INDICATION; DRUG SAFETY; EMERGENCY WARD; FIBRINOLYTIC THERAPY; HEALTH CARE ORGANIZATION; HEART ATRIUM FIBRILLATION; HUMAN; NOTE; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; COMPLICATION; DRUG SUBSTITUTION; EMERGENCY HEALTH SERVICE; EMERGENCY TREATMENT; ORAL DRUG ADMINISTRATION; PROCEDURES; STROKE;

ADMINISTRATION, ORAL; ANTICOAGULANTS; ANTIDOTES; ATRIAL FIBRILLATION; DRUG SUBSTITUTION; EMERGENCY SERVICE, HOSPITAL; EMERGENCY TREATMENT; HUMANS; STROKE;

EID: 84905028018     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu250     Document Type: Note

References (5)

1. Steiner T, Böhm M, Dichgans M, Diener HC, Ell C, Endres M, Epple C, Grond M, Laufs U, Nickenig G, Riess H, Röther J, Schellinger PD, Spannagl M, Veltkamp R. Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban. Clin Res Cardiol 2013;102:399-412
2. Hart RG, Diener HC, Yang S, Connolly SJ, Wallentin L, Reilly PA, Ezekowitz MD, Yusuf S. Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: The RE-LY trial. Stroke 2012;43:1511-7 (Epub 12 April 2012
3. Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM. Comparison of the efficacy and safety ofnew oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-Analysis of randomised trials. Lancet 2013;383:955-62.
4. Van Ryn J, Stangier J, Haertter S, Liesenfeld KH, Wienen W, Feuring M, Clemens A. Dabigatran etexilate-A novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 2010;103:1116-27
5. Lu G, DeGuzman FR, Hollenbach SJ, Karbarz MJ, Abe K, Lee G, Luan P, Hutchaleelaha A, Inagaki M, Conley PB, Phillips DR, Sinha U. A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa. Nat Med 2013;19:446-51.